Symbol: |
KCTD2
|
Description: |
potassium channel tetramerisation domain containing 2 [Source:HGNC Symbol;Acc:21294]
|
Location: |
Chr17:73028670-73061984[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:175
Gene |
Compound |
Gen_sig |
Exp_pattern |
KCTD2 |
Ethanamine, N,N-dimethyl-2-[4-(1,1-dimethylethyl)- 1-[(4-methylphenyl)methyl]cyclohexyloxy]-, (trans)-, (E)-2-butenedioate (fumaric acid) (1:1) |
0.021 |
Up |
KCTD2 |
NSC 670314 |
0.012 |
Up |
KCTD2 |
NSC 670785 |
0.047 |
Down |
KCTD2 |
2-Iodoestradiol |
0.007 |
Up |
KCTD2 |
NSC 671811 |
0.049 |
Down |
KCTD2 |
NSC 672768 |
0.032 |
Down |
KCTD2 |
NSC 672880 |
0.014 |
Down |
KCTD2 |
NSC 673104 |
0.015 |
Down |
KCTD2 |
NSC 673507 |
0.028 |
Up |
KCTD2 |
Pyrazino[1,2-a]benzimidazole, 1,3-diphenyl- |
0.045 |
Down |
KCTD2 |
Pyrazino[1,2-a]benzimidazole, 3-(4-methylphenyl)- 1-phenyl- |
0.015 |
Down |
KCTD2 |
NSC 674289 |
0.013 |
Up |
KCTD2 |
NSC 674953 |
0.013 |
Down |
KCTD2 |
1H-1,2,4-Triazole-5(4H)-one, 4-[[(4-nitrophenyl)methylene] amino]-3-phenyl- |
0.002 |
Down |
KCTD2 |
NSC 676334 |
0.026 |
Down |
Expression pattern: Sensitivity / Resistance
Total:12 Current:5
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:55
Total:4 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:null
Gene |
Gen_transcript |
miRNA |
miR_location |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|